The proteomics market is growing rapidly as researchers and pharmaceutical companies increasingly use protein analysis to understand diseases, discover biomarkers, develop drugs, and support precision medicine.
According to MarketsandMarkets™, the global proteomics market is projected to reach USD 67.55 billion by 2031, up from USD 39.84 billion in 2026, at a CAGR of 11.1% during the forecast period.
Increasing investment in life sciences research, growing demand for biomarker discovery, advancements in mass spectrometry, and the rising adoption of personalized medicine are supporting the growth of the global protein analysis market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731
What Is Proteomics?
Proteomics is the large-scale study of proteins, including their structure, function, interactions, abundance, and modifications.
Proteomics technologies help researchers understand biological processes and identify changes in proteins associated with diseases.
Common applications include:
- Protein identification and quantification
- Biomarker discovery
- Drug discovery and development
- Disease research
- Precision medicine
- Protein characterization
- Post-translational modification analysis
- Clinical and translational research
As the demand for advanced biological research increases, the adoption of proteomics technologies is expected to continue growing.
Key Factors Driving the Proteomics Market
Growing Demand for Biomarker Discovery
Biomarker discovery is one of the important applications supporting the proteomics market.
Researchers use protein analysis to identify potential biomarkers that can help understand diseases and support the development of diagnostic and therapeutic approaches.
The growing focus on early disease detection and personalized medicine is creating additional opportunities for proteomics companies.
Increasing Adoption of Mass Spectrometry
Mass spectrometry is an important technology used in modern proteomics workflows.
Advances in mass spectrometry proteomics are helping researchers analyze proteins with greater speed, sensitivity, and accuracy.
Improved instruments and software are also enabling researchers to study increasingly complex biological samples.
Rising Demand for Precision Medicine
Precision medicine is increasing the need for detailed molecular information from individual patients.
Proteomics can provide information about protein expression and biological changes that may complement genomic and other molecular data.
This is creating opportunities for proteomics technologies in pharmaceutical research, clinical research, and translational medicine.
Growing Pharmaceutical and Biotechnology Research
Pharmaceutical and biotechnology companies are increasingly using protein analysis throughout drug discovery and development.
Proteomics can support target identification, biomarker discovery, mechanism-of-action studies, and protein characterization.
As investment in drug development increases, demand for proteomics solutions and services is also expected to rise.
Major Proteomics Technologies
The proteomics industry includes several technologies and tools used throughout protein analysis workflows.
Mass Spectrometry
Mass spectrometry is widely used for protein identification, quantification, and characterization.
Modern mass spectrometers are becoming more powerful and capable of analyzing complex samples, making them an important part of proteomics research.
Liquid Chromatography
Liquid chromatography is commonly combined with mass spectrometry to separate complex protein and peptide samples before analysis.
Advancements in LC-MS workflows are improving analytical performance for pharmaceutical and research applications.
Protein Microarrays
Protein microarrays can be used to analyze interactions between proteins and other biological molecules.
They have applications in biomarker research, drug discovery, and functional protein analysis.
Bioinformatics and Proteomics Software
The increasing volume of proteomics data is driving demand for advanced software and bioinformatics tools.
These solutions help researchers process, analyze, interpret, and visualize large datasets generated by proteomics experiments.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=731
Key Applications of the Proteomics Market
Proteomics technologies are used across pharmaceutical, biotechnology, academic, and research environments.
Important applications include:
Drug Discovery: Proteomics helps researchers understand disease pathways and identify potential therapeutic targets.
Biomarker Discovery: Protein analysis can help identify biomarkers associated with diseases and biological processes.
Clinical Research: Proteomics supports translational research by providing protein-level insights into disease mechanisms.
Protein Characterization: Pharmaceutical companies use proteomics tools to characterize biological products and investigate protein properties.
Precision Medicine: Proteomic information can complement genomic data to support a more comprehensive understanding of individual biological profiles.
Key Companies in the Proteomics Market
The global proteomics market includes several major life science and analytical instrumentation companies.
Key players include:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Merck KGaA
- Danaher Corporation
- Shimadzu Corporation
- Waters Corporation
- Bio-Rad Laboratories, Inc.
- Bruker
- Revvity
- Illumina, Inc.
These companies are investing in product launches, collaborations, acquisitions, agreements, and expansions to strengthen their positions in the global proteomics industry.
Thermo Fisher Scientific
Thermo Fisher Scientific is a major company in the proteomics market, offering technologies across mass spectrometry, sample preparation, reagents, separation, and software.
Its solutions support protein identification, protein quantification, biomarker discovery, post-translational modification analysis, and translational research.
In April 2026, Thermo Fisher entered a strategic collaboration with PRECISE to advance population-scale proteomics. The program combines Olink Proximity Extension Assay platforms with the Orbitrap Astral mass spectrometry system for precision medicine and longitudinal cohort research.
Agilent Technologies
Agilent Technologies provides solutions across liquid chromatography, LC/MS systems, protein analysis, sample preparation, and software.
Its technologies support applications such as biomarker research, protein characterization, pharmaceutical analysis, and broader omics research.
In May 2025, Agilent launched the InfinityLab Pro iQ Series, including the Pro iQ and Pro iQ Plus systems, for LC-mass detection applications involving peptides, proteins, small molecules, and oligonucleotides.
Merck KGaA
Merck provides a broad portfolio of products supporting proteomics workflows.
Its offerings include products for protein sample preparation, purification, filtration, enzymes, standards, mass spectrometry workflows, and biomarker research.
These solutions support researchers across protein extraction, digestion, enrichment, purification, and downstream protein analysis.
Proteomics Market Competitive Landscape
The proteomics market is moderately consolidated, with major life science and analytical technology companies competing through advanced instruments, reagents, software, sample preparation technologies, and integrated workflows.
Thermo Fisher Scientific has a strong position through its broad proteomics portfolio and integrated mass spectrometry solutions.
Agilent Technologies competes through its expertise in liquid chromatography, mass spectrometry, protein analysis, and data-management solutions.
Merck KGaA supports the market through its extensive range of reagents, sample-preparation products, purification technologies, and workflow consumables.
Other major players are also investing in new technologies and strategic partnerships to address the growing demand for faster, more accurate, and scalable protein analysis.
Emerging Trends in Proteomics
Several trends are expected to shape the future of the proteomics industry.
Population-Scale Proteomics
Large-scale proteomics studies are gaining importance as researchers seek to understand relationships between proteins, diseases, and patient characteristics across large populations.
Artificial Intelligence in Proteomics
AI and machine learning are increasingly being explored for proteomics data analysis.
These technologies can help researchers process large datasets and identify patterns that may be difficult to detect using conventional analysis approaches.
Multi-Omics Integration
Proteomics is increasingly being combined with genomics, transcriptomics, metabolomics, and other omics technologies.
Multi-omics approaches can provide researchers with a more comprehensive view of biological systems.
Automation
Automation of sample preparation and analytical workflows is becoming increasingly important.
Automated workflows can help improve throughput, reproducibility, and efficiency in high-volume proteomics laboratories.
Future Outlook
The future of the proteomics market looks promising as demand for advanced protein analysis continues to increase.
Growing pharmaceutical research, increasing biomarker discovery activities, advancements in mass spectrometry, rising adoption of precision medicine, and the expansion of population-scale studies are expected to create new market opportunities.
The integration of proteomics with artificial intelligence, bioinformatics, automation, and other omics technologies is also expected to expand the applications of protein analysis.
With the global market projected to reach USD 67.55 billion by 2031, companies involved in proteomics instruments, reagents, software, services, and analytical technologies have significant opportunities to expand their businesses.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=731
